2014
DOI: 10.1007/s13311-014-0278-x
|View full text |Cite
|
Sign up to set email alerts
|

Neuropathic Pain and Deep Brain Stimulation

Abstract: Deep brain stimulation (DBS) is a neurosurgical intervention the efficacy, safety, and utility of which are established in the treatment of Parkinson's disease. For the treatment of chronic, neuropathic pain refractory to medical therapies, many prospective case series have been reported, but few have published findings from patients treated with current standards of neuroimaging and stimulator technology over the last decade . We summarize the history, science, selection, assessment, surgery, programming, and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
81
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(81 citation statements)
references
References 181 publications
0
81
0
Order By: Relevance
“…A review examining DBS with motor and sensory cortical stimulation examines all recent prospective studies examining long-term outcomes in patients and advocate that DBS is superior to motor cortical stimulation for refractory pain syndromes and may be more appropriate than sensory cortical stimulation for certain pain etiologies, including phantom pain after amputation [45]. In regards to pain after stroke, DBS reveals greatest efficacy for stroke patients complaining of burning hyperaesthesia [18].…”
Section: Issn: 2373-8995mentioning
confidence: 99%
“…A review examining DBS with motor and sensory cortical stimulation examines all recent prospective studies examining long-term outcomes in patients and advocate that DBS is superior to motor cortical stimulation for refractory pain syndromes and may be more appropriate than sensory cortical stimulation for certain pain etiologies, including phantom pain after amputation [45]. In regards to pain after stroke, DBS reveals greatest efficacy for stroke patients complaining of burning hyperaesthesia [18].…”
Section: Issn: 2373-8995mentioning
confidence: 99%
“…Targets now include the thalamus, internal capsule, periaqueductal grey matter and cingulate gyrus for treating chronic pain syndromes. [16][17][18] Over recent years, the use of DBS for chronic pain has expanded to include indications such as peripheral nerve injuries, plexopathies and amputation pain, stroke and neurological disease such as multiple sclerosis. [16][17][18][19] During intraoperative use of DBS to guide lesioning surgery for epilepsy and movement disorders in the 1950s-70s, it was noted that there was an improvement in dyskinesia and Parkinsonian tremor.…”
Section: Deep Brain Stimulationmentioning
confidence: 99%
“…[16][17][18] Over recent years, the use of DBS for chronic pain has expanded to include indications such as peripheral nerve injuries, plexopathies and amputation pain, stroke and neurological disease such as multiple sclerosis. [16][17][18][19] During intraoperative use of DBS to guide lesioning surgery for epilepsy and movement disorders in the 1950s-70s, it was noted that there was an improvement in dyskinesia and Parkinsonian tremor. 9,20,21 Despite this, the success of Parkinson's medical therapy and the already established lesioning surgery meant the introduction of therapeutic use of DBS for these conditions was delayed until the late 1980s.…”
Section: Deep Brain Stimulationmentioning
confidence: 99%
“…Its use in movement disorders is reviewed in this issue by Larson [1]. With the success of DBS in treating movement disorders, the possibility of taking on other disorders is now in sight, and clinical studies in various phases of development are underway in a number of disorders, including depression (Morishita et al [2]), obsessive compulsive disorder (Lapidus et al [3]), pain (Pereira and Aziz [4]), epilepsy (Laxpati et al [5]) , and even disorders of memory and cognition (Sankar et al [6]). There is also the realization that other peripheral targets may be useful.…”
Section: Implanted Devices Can Be Targeted Quite Precisely To Affectmentioning
confidence: 99%